tirzepatide fda news https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound 🌟 Exciting News Alert! 🌟

While most fertility benefits of GLP-1s are linked to weight loss and improved metabolic health, some early research suggests these medications may also have direct effects on the reproductive system

Acetyl L-carnitine functions as an antioxidant and promotes the production of glutathione, a free radical scavenger, in cells.* Acetyl-L-Carnitine passes the blood-brain barrier to enhance brain performance* Supports focus and mental clarity which reduces feelings of brain fog* *These statements have not been evaluated by the Food and Drug Administration

Foretz, M

Jeff Bastien, President Apex Benefits Partners

Beginning at 2.5 mg may reduce side effects such as nausea or stomach discomfort before increasing the dose